Showing 1 posts of 1 posts found.
Roche has said its experimental drug, gantenerumab, did not meet its primary endpoint in people who have an inherited form …
Acumentis CEO Herspiegel steps down as Burden assumes role
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia
Hot-tub therapy tested as potential treatment for peripheral artery disease
Raimond takes helm at Nuclera
Most advanced breast cancer patients treated in community settings, Phesi study finds